Side-by-side financials for ADAG and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADAG | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $7.67M | - |
| Net income (latest FY) | -$17.61M | - |
| Net margin | -229.6% | - |
| SEC filings | 171 | 1,004 |
Full pages: Adagene Inc. and AstraZeneca PLC, or browse the full rankings.